Potential involvement of monocyte chemoattractant protein (MCP)-1/CCL2 in IL-4-mediated tumor immunity through

Hui Wang1, Yoko Nemoto-Sasaki, Toshikazu Kondo

  • 1Division of Molecular Bioregulation, Cancer Research Institute, Kanazawa University, 13-1 Takara-machi, Kanazawa 920-0934, Japan.

Insights

Interleukin-4 (IL-4) gene transfer into colon cancer cells triggers anti-tumor immunity. Monocyte chemoattractant protein-1 (MCP-1) drives dendritic cell migration, crucial for IL-4-mediated tumor rejection.

Area of Science:

  • Immunology
  • Cancer Biology
  • Molecular Biology

Background:

  • Interleukin-4 (IL-4) gene transduction into colon 26 adenocarcinoma cells abrogates tumorigenicity.
  • This effect is mediated by the generation of anti-tumor cytotoxic T lymphocytes (CTL).

Purpose of the Study:

  • To investigate the role of dendritic cell (DC) populations and chemokine expression in IL-4-mediated tumor rejection.
  • To elucidate the specific chemokines and receptors involved in DC migration to draining lymph nodes.

Main Methods:

  • Analysis of DEC-205 and CD11c double-positive cells in mouse lymph nodes post-tumor cell injection.
  • Quantification of chemokine and receptor gene expression (MCP-1/CCL2, CCL22, CCL20, CCR2) in draining lymph nodes.
  • Administration of anti-MCP-1/CCL2 antibodies to assess the impact on tumor regression and DC migration.

Main Results:

  • IL-4-transfected cells increased DEC-205+/CD11c+ cells expressing CD86 in lymph nodes.
  • Enhanced gene expression of MCP-1/CCL2, CCL22, and CCL20 was observed in draining lymph nodes.
  • CCR2, the receptor for MCP-1/CCL2, was upregulated in draining lymph nodes, with DEC-205+ cells expressing CCR2.
  • Anti-MCP-1/CCL2 antibody administration hindered tumor regression and reduced DC numbers in lymph nodes.

Conclusions:

  • Locally produced Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) is critical for IL-4-mediated tumor rejection.
  • MCP-1/CCL2 likely induces dendritic cell migration into draining lymph nodes, initiating an anti-tumor immune response.

Related Concept Videos

The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...